The Clinical Significance of Measuring Different Anti-dsDNA Antibodies by Using the Farr Assay, an Enzyme Immunoassay and a Crithidia luciliae Immunofluorescence Test
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Anti-double-stranded DNA (dsDNA) antibodies are highly specific for the diagnosis of systemic lupus erythematosus (SLE) but are heterogeneous in respect to, for example, avidity, class and cross-reactivity. Sera from 2061 patients were measured by three methods: an enzyme-linked immunosorbent assay (ELISA), an indirect immunofluorescence test with Crithidia luciliae as substrate (CLIF), and the Farr assay, a radioimmunological method based on the ammonium sulfate precipitation of immune complexes. The different anti-dsDNA antibody determinations were evaluated by analysis of patient records. The reason for a reactive Farr assay in 14 patients was predominantly the measurement of antibodies of the IgM class, which are not detected by the ELISA. The detection of additional antibodies to dsDNA of the IgA class, to single-stranded DNA or to histones plays a minor role. In comparison with the Farr assay, we found more positive results with the ELISA, which additionally detects anti-dsDNA antibodies of low avidity. The ELISA might also yield positive values in conditions such as chronic liver diseases, various infections and connective tissue diseases other than SLE. Avoiding the disadvantages of radioactivity, the ELISA is well suited as a screening test for dsDNA antibodies. However, positive results should be confirmed by the CLIF test or preferably by the Farr assay, thus combining sensitivity with specificity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most clinical laboratories use commercially available kits to detect and quantify anti-dsDNA autoantibodies (e.g. ELISA, CLIFT, FEIA, CIA, multiplexed assay), sometimes in combination [89, 90].”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [89]
In the citing paper
“Most commercial ELISA systems have great advantages in routine laboratory testing but may detect not specific anti-dsDNA Abs, which results in false positives in non-SLE patients [[22], [23]].”
From Anti-double stranded DNA antibodies: A rational diagnostic approach in limited-resource settings (2022) · cites this paper as [23]
In the citing paper
“Many test methods are available and anti-dsDNA tests, by design, detect different subpopulations of anti-dsDNA with distinct fine specificities (16,20,(22)(23)(24).”
From Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review. (2022) · cites this paper as [22]
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Autoantibodies to Nuclear Antigens (ANA): Their Immunobiology and Medicine
Tan, E. M. (1982) · Advances in Immunology · doi:10.1016/s0065-2776(08)60836-6 · Cited by 965
Ter Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330505 · Cited by 572
Aarden, L. A., Groot, E. R. D., & Feltkamp, T. E. W. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb29197.x · Cited by 563
Prognostic value of anti-dsDNA in SLE.
Swaak, A. J. G., Groenwold, J., Aarden, L. A., van Eps, L. W. S., & Feltkamp, E. W. (1982) · Annals of the Rheumatic Diseases · doi:10.1136/ard.41.4.388 · Cited by 120
Anti-dsDNA: choice of assay in relation to clinical value
Smeenk, R. J. T., van den Brink, H. G., Brinkman, K., Termaat, R. M., Berden, J. H. M., & Swaak, A. J. G. (1991) · Rheumatology International · doi:10.1007/bf00304496 · Cited by 75
Brinkman, K., Termaat, R.-M., de Jong, J., van den Brink, H. G., Berden, J. H. M., & Smeenk, R. J. T. (1989) · Research in Immunology · doi:10.1016/0923-2494(89)90122-3 · Cited by 68
A new ELISA for the detection of double-stranded DNA antibodies
Emlen, W., Jarusiripipat, P., & Burdick, G. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90402-h · Cited by 67
Field, M., Williams, D. G., Charles, P. J., & Maini, R. N. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.10.820 · Cited by 51
Tzioufas, A. G., Manoussakis, M. N., Drosos, A. A., Silis, G., Gharavi, A. E., & Moutsopoulos, H. M. (1987) · Clinical and Experimental Rheumatology · Cited by 49
Research works printed but not linked: 13
- Hughes Grv. Systemic lupus erythematosus. In: Connective Tissue Diseases . Oxford: Blackwell Scientific Publications , 1977:3-65.
- Tzioufas AG, 1987, Clin Exp Rheumatol, 5, 247
- Wallace DJ, 1987, Lupus Erythematosus
- Henderson T., 1987, Clin Immunol, 5, 20
- Blazek M., 1991, Lab Med, 15, 490
- Rauterberg EW, 1989, Lab Med, 13, 287
- Laplanche S., 1990, Ann Biol Clin, 48, 177
- Mackworth-Young C., 1982, Crit Rev Immunol, 8, 147
- Eilat D., 1986, Clin Exp Immunol, 65, 215
- Schmolke B., 1990, Lab Med, 14, 363
- Preud'homme JL, 1988, Presse Med, 27, 1401
- Froehlich CJ, 1990, J Rheumatol, 17, 192
- Humbel R., 2nd European Symposium of Anti-nuclear and Anti-cytoplasmatic Antibodies in Inflammatory Connective Tissue Diseases
Cited by
The use of laboratory tests in the diagnosis of SLE
Egner, W. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.6.424 · Cited by 316
De Rycke, L., Kruithof, E., Van Damme, N., Hoffman, I. E. A., Van den Bossche, N., Van den Bosch, F., Veys, E. M., & De Keyser, F. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10876 · Cited by 223
de Rycke, L., Baeten, D., Kruithof, E., Van den Bosch, F., Veys, E. M., & de Keyser, F. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21190 · Cited by 172
Autoantibody Determination in the Diagnosis of Systemic Lupus Erythematosus
Kurien, B. T., & Scofield, R. H. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01819.x · Cited by 120
Bootsma, H., Spronk, P. E., Borg, E. J. T., Hummel, E. J., de Boer, G., Limburg, P. C., & Kallenberg, C. G. M. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.11.661 · Cited by 115
Metadata
- Authors
- Werle, E., Blazek, M., & Fiehn, W.
- Affiliations
- Heidelberg University (DE)
- ORCID
- Blazek, Marta
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 1992-12
- Volume
- 1
- Issue
- 6
- Pages
- 369-377
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W2012682395
- Semantic Scholar
- cbb69e0852df23293b98aa325a1341b5a01c0bee
- Cited by
- 39
- References
- 25
- Citations by year
- 2026: 1 · 2024: 1 · 2022: 5 · 2021: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Lupus (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- anti-dsDNA antibodies, systemic lupus erythematosus, Farr assay, enzyme-linked immunosorbent assay, IgM, IgA antibodies, single-stranded DNA antibodies, histone antibodies, antibody avidity, false positives, screening test
- MeSH terms
- Animals, Antibodies, Antinuclear, Crithidia, DNA, Enzyme-Linked Immunosorbent Assay, Fluorescent Antibody Technique, Humans, Immunoglobulin G, Immunoglobulin M, Lupus Erythematosus, Systemic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Clinical Significance of Measuring Different Anti-dsDNA Antibodies by Using the Farr Assay, an Enzyme Immunoassay and a Crithidia luciliae Immunofluorescence Test. https://app.cochat.ai/papers/10.1177/096120339200100606
- The paper
- Werle, E., Blazek, M., & Fiehn, W. (1992). The Clinical Significance of Measuring Different Anti-dsDNA Antibodies by Using the Farr Assay, an Enzyme Immunoassay and a Crithidia luciliae Immunofluorescence Test. Lupus. https://doi.org/10.1177/096120339200100606
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.